BACKGROUND/OBJECTIVES: Malnutrition decreases the cancer patient's ability to manage treatment, affects quality of life and survival, and is common among head and neck (HN) cancer patients due to the tumour location and the treatment received. In this study, advanced HN cancer patients were included and followed during 2 years in order to measure their energy intake, choice of energy sources and to assess problems with dysphagia. The main purpose was to explore when and for how long the patients had dysphagia and lost weight due to insufficient intake and if having a PEG (percutaneous endoscopic gastrostomy) in place for enteral nutrition made a difference. SUBJECTS/METHODS: One hundred thirty-four patients were included and randomised to either a prophylactic PEG for early enteral feeding or nutritional care according to clinical praxis. At seven time points weight, dysphagia and energy intake (assessed as oral, nutritional supplements, enteral and parenteral) were measured. RESULTS: Both groups lost weight the first six months due to insufficient energy intake and used enteral nutrition as their main intake source; no significant differences between groups were found. Problems with dysphagia were vast during the 6 months. At the 6-, 12-and 24-month follow-ups both groups reached estimated energy requirements and weight loss ceased. Oral intake was the major energy source after 1 year. CONCLUSIONS: HN cancer patients need nutritional support and enteral feeding for a long time period during and after treatment due to insufficient energy intake. A prophylactic PEG did not significantly improve the enteral intake probably due to treatment side effects.
INTRODUCTION
It is well known that malnutrition is common among patients with head and neck (HN) cancer, both during active treatment as well as for a long period after treatment. 1, 2 Many factors contribute; the metabolic changes due to the cancer, the side effects of treatment and last but not least the HN cancer location in itself. [3] [4] [5] Previously, it has been found that malnutrition enhances the risk for operative complications and interrupted treatment, as well as decreases quality of life and survival rate. 1, [6] [7] [8] Intervention studies have been performed aimed at preventing and/or reducing weight loss and the number of patients who are malnourished; the implementation of nutritional counseling by dieticians, use of drugs, nutritional supplement and enteral feeding have all shown promising results. Most of these studies however involve relatively few patients and the studied time period seldom exceeded 6 months. 9 Lately, placement of a percutaneous endoscopic gastrostomy (PEG) tube for enteral feeding has become more common in an attempt to prevent malnutrition; however, few randomized studies have been published comparing whether this is more advantageous than using a nasogastric tube. 10, 11 We recently published a randomized study comparing the effect of a prophylactic PEG for early enteral feeding to the nutritional care according to clinical praxis for patients with advanced oral or pharyngeal HN cancer. 12 The study had two aims; the first was to examine whether early enteral feeding using PEG could prevent malnutrition and improve quality of life and reduce the need for hospital care. The published first part of the study concluded that B10% fewer patients were malnourished in the study group at each time point compared with the control group during the first year and the study group had significantly better quality of life at the 6 month follow-up, but no difference regarding length of hospital stay was found. Discouragingly, 62% in the study group were malnourished after 6 months despite the possibility for nutritional advice on a continuous basis and access to using the PEG for enteral feeding when needed. 13 Another aim with the study was to the patients' energy sources over time and to what extent they reached their energy requirements.
In the second part of the study, presented here, the aim was to thoroughly examine and compare the study and control groups' energy sources (oral, enteral, parenteral and nutritional supplements) over time and to what extent they reached their recommended energy requirements by analyzing the patients' 3-day food records longitudinally at seven time points during 2 years. The patient's ability to swallow over time is also explored and compared by using the EORTC QLQ-HN swallowing scale.
MATERIALS AND METHODS

Study design
Sahlgrenska University Hospital, Sweden, during February 2002 to December 2006. The study was performed with two treatment arms: the study group was randomised to a prophylactic PEG for early enteral feeding and nutrional advice when needed and the control group had standard nutritional care. Both groups were followed for 2 years and controlled at seven different time points, at inclusion and after 1, 2, 3, 6, 12 and 24 months.
At each follow-up both the study group and the control group filled in their 3-day food records before clinic visit also noting the different energy sources used. At all follow-ups the patient's caloric intake was calculated, the current weight was measured and problems with swallowing were also noted. The patients also filled in the health-realted quality-of-life questionnaires. The two randomised groups were analysed separately in order to examine whether there were any differences between the groups.
The study was approved by the local ethical committee and all patients signed a written informed consent.
Study population
Patients diagnosed with oral or pharyngeal cancer or neck lymph node metastases with unknown primary in stage III or IV were eligible for the study. Inclusion criteria were newly diagnosed patients who were considered for curative treatment. Exclusion criteria were palliative treatment, difficulties to follow the protocol or participation in another clinical study. In total, 202 patients fulfilled the inclusion criteria but 57 patients did not agree to participate in the study, thus 145 patients were randomised to either the study group (n ¼ 73) or the control group (n ¼ 72). After randomisation, 11 patients were withdrawn due to various reasons (five patients withdrew their participation, two patients died and two patients due to technical difficulties with the PEG, two patients changed to palliative treatment). The remaining 134 patients started the study, 64 patients in the study group and 70 in the control group. Only patients completing at least one food record were included in this part of the study (n ¼ 127/134).
Dietary assessment
Three-day food records were used to assess the dietary intake and as guidance for diet counselling.
14 At inclusion, all patients and their accompanying persons were informed by a dietician how to record the food intake. The information was repeated, if required at each visit. The patient filled in the food records during 2 week days and 1 weekend day. The food records were sent by mail to the clinic and checked by a dietician. In case of incomplete records, the patients were contacted by telephone. The energy sources were divided into oral intake of food, oral nutritional supplements (ONS), enteral nutrition and parenteral nutrition and the energy in kcal attributed to the four nutrition source was calculated by dieticians.
Nutritional requirements
Patients were recommended 30 kcal per kg bodyweight. At each visit the requirements were recalculated according to patient's weight in order to maintain the current bodyweight. For patients with body mass index 425 kg/m 2 was the recommended intake calculated from their ideal weight corresponding to body mass index 25 kg/m 2.15 The recommended protein intake was 1.2-1.5 g per kg bodyweight. 15 
Nutritional counselling
All patients in the study group were given individual nutritional counselling by a dietician based on nutritional status, food records and perceived eating problems. The control group was given counselling according to general clinical praxis. General clinical praxis could include nutritional advice given by any nursing staff, and enteral and parenteral nutrition.
Anthropometrical measures
Body height was measured at inclusion in centimetres. Bodyweight was measured at each visit during the study. Weight was measured on the same scale, a calibrated Lindetronic 8000 M, in kg and one decimal. Body mass index was calculated as weight (kg) divided by height squared (m 2 ).
Nutritional status assessment
Malnutrition was assessed by calculating the percentage weight loss compared with the patient's weight assessed at inclusion and every visit thereafter. Malnutrition was classified as unintended weight loss 410% the last 6 months. 16 
Dysphagia
To measure each patient's quality of life, two self-administered questionnaires, the EORTC QLQ-C30 and QLQ-HN35 (The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core 30 and HN module), were used and the results have been published previously. 12 In this part of the study, focusing on food intake and dysphagia, only the results from the single items in the EORTC HN-35 swallowing scale is analysed. 17 The swallowing scale consists of four questions assessing problems with swallowing, problems with swallowing solid food, pureed food, liquids and choked when swallowing. The scores for the single items are shown separately in order to illustrate the implications of swallowing problems over time. The score ranges from 0-100, where the higher the score the more problems. 18 
Statistical analyses
All patients who recorded their food intake at any time point were included in the analysis.
The intake of food-, enteral-and parenteral nutrition and nutritional supplements was calculated using the food calculation software program AIVO Diet 32.
The results are presented as means, median, range and percent. For comparison between groups Mann-Whitney U-test was used for continuous variables, Fisher's Exact test for dichotomous variables, Mantel-Haenszel w 2 -test for ordered categorical variables and the w 2 -test for non-ordered categorical variables.
The significance level was set at Po0.05. Statistical analyses were conducted using SAS software (SAS, Inc., Cary, NC, USA), version 9.2.
For the EORTC QLQ-HN35 questionnaire a change of score between measurement points or between groups of 10 points or more was considered a clinical significant difference. 19 
RESULTS
Patient characteristics at inclusion, type of treatment and survival are presented for the study group (n ¼ 62) and the control group (n ¼ 65) in Table 1 ; no significant difference between the two groups was found. The majority of patients were men and the most common tumour location in both groups was tonsilar carcinoma (40% in the study group vs 36% control group) followed by tongue base carcinoma (23 vs 24%). The most common treatment modality was chemoradiotherapy (71 vs 74%). Only 26% of the patients in both groups were living alone.
Compliance
The number of patients who completed food records at any of the seven time points is presented in Table 2 . The compliance was between 82-100% in the study group and 74-89% in the control group (calculated as number of food records/number of patients alive). In total, 722 of 819 (88%) possible food records were completed during the 2-year intervention study.
Energy and protein intake and weight loss Reported energy intake per current kg bodyweight (kcal/kg) in relation to recommended energy requirements (30 kcal/kg per day) as well as weight loss during the study are illustrated in Figure 1 . Neither the study group nor the control group reached recommended energy requirements at inclusion, that is, at time of diagnosis of the cancer. The intake continued to be lower than the recommended intake at the 1-, 2-and 3-month follow-ups after treatment start. The lowest energy intake level was found at the 2-month follow-up in both groups. At the first four time points the study group's energy intake had a tendency to be higher than the controlgroup's; the differences varied between 1.5-2.9 kcal/kg but no statistical significant differences were found at any time points. The largest difference was found at the 3-month follow-up, representing a 10% difference (27.9 
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.0 kcal/kg, P ¼ 0.09). After 3 months both groups had lost 7% of their initial bodyweight (5.3 vs 5.6 kg). After 6 months the patients had lost 11% of their bodyweight in the study group and 12% in the control group (8.8 vs 9.0 kg). At the 6, 12 and 24-month followups both groups reached estimated energy requirements and weight loss ceased. Neither the study group nor the control group reached the recommended protein requirements until the 6-month follow-up (0.9-1.0 g/kg). At time points thereafter, both groups reached the recommended requirement (1.3 g/kg).
Energy intake and sources of nutrition over time Figures 2a and b show the total energy intake presented by source of nutrition at seven time points in relation to energy requirements in the study and control groups.
The proportion of oral intake varied over time in both groups. At diagnosis oral intake was the main source (93% in the study group and 91% in the control group) supported by a small proportion of ONS (6 vs 7% of the intake). The oral intake decreased at the following three time points, and was 30 vs 44% (P ¼ 0.15) of the total intake at the 2-month follow-up and only 22 vs 29% (P ¼ 0.63) of the total intake at the 3-month follow-up. At the 1-and 2-year follow-ups the study group achieved an intake above 30 kcal/kg and 86% respective 93% was attributed to oral intake (ONS excluded). The control group achieved an intake nearly the recommended requirements at 12 months and just below at the 24-month follow-up and the proportion of oral intake was somewhat lower compared with the study group, that is, 83% at the 12-month follow-up and 86% after 24 months.
Enteral nutrition was the main energy contributor at the 2-and 3-month follow-ups. At 2 months the percent energy intake from enteral nutrition was 69% and 49% in the study group and control group, respectively. Corresponding figures at 3 months were 72% and 62%, respectively.
The percentage ONS used at the same time points was10% at 3 and 6 months in the control group and in the study group 6% and 10%, respectively. At 24 months both groups continued to use enteral nutrition and ONS but the energy intake from enteral nutrition was lower in the study group (4.2 vs 9.3%). Corresponding percentages for ONS intake were 2.8% and 4.4%, respectively.
The use of parenteral nutrition was low throughout the study in both groups. Dysphagia Eating problems reported by the patients are shown in Figures  3a-d . Difficulties in eating solid foods, pureed foods as well as liquids were most pronounced at the 2-and 3-month follow-ups in both groups. There was a clinically significant increase in problems for all three food types, but as expected a significant difference was also shown between problems swallowing liquids compared with pureed food as well as between swallowing pureed food compared with solid food. At the 2-month follow-up 75% in the study group and 63% in the control group reported that they had 'much' or 'very much' problems to swallow solid food and after 3 months 82% in both groups reported having 'much' or 'very much' problems.
After 6 months the patients still reported problems although to a lesser extent. After 2 years the patients had little problems Figure 1 . The energy intake of the study and control groups calculated as kcal per kg bodyweight at the seven measurement points during the study. The recommended intake was 30 kcal per kg bodyweight per day throughout the study. In addition, also shows weight loss (measured bodyweight (kg) at the different time points compared with measured bodyweight at inclusion in the study).
Energy intake and energy sources in HN cancer patients E Silander et al swallowing liquid or pureed food but still had problems with solid food. There were no significant differences between the two groups at those time points but the study group's problems with solid food had increased compared with at time of diagnosis. Problems with choked when swallowing increased after diagnosis and remained a significant problem at the last followup with only small differences found between the two groups.
DISCUSSION
This randomised study describes the ability of advanced HN cancer patients to swallow and nourish themselves with a percutaneous endoscopic gastrostomi (study group) or according to clinical practise (control group) assessed at seven different time points during a 2-year period. For calculating the energy intake and identifying nutrient sources a 3-day food record was used, a method requiring efforts from both the patients and dieticians, which has been evaluated to be a reliable method. 14 The study group did not achieve their recommended energy requirements of 30 kcal/kg per day during the first 3 months despite support from dieticians and the possibility to use a feeding tube (PEG) for early enteral nutrition. They managed an intake of 82-90% of their recommended requirements, subsequently leading to quite a substantial but slow weight loss. One can only speculate as to why they did not manage to reach their energy requirements: the majority (71%) were treated with chemoradiotherapy (two cycles of induction cisplatin and 5-Flourouracil and hyperfractionated accelerated radiotherapy). Well-known side effects (nausea, vomiting, mucositis and local pain) could all have affected their ability to consume at the first and second measurement points. This is supported by Nguyen et al., 20 who reported that 86% of the HN cancer patients in their study had grade III or IV mucositis during chemoradiation therapy and a comparable weight loss despite tube feeding. This could also explain the small differences between the study and control groups in this study. Thus, the answer to the question as to what is the optimal upper limit of energy intake during chemoradiotherapy and how to improve the intake still remains to be answered. Jager-Wittenaar et al. and van den Berg et al. 21, 22 have both reported that HN cancer patients were able to reach their energy requirements after treatment (32-38 kcal/kg) but the patients still lost weight (no energy intake was calculated during treatment). An explanation for the discrepancy between these findings and our study could be that the energy intake was calculated using a different method, food frequency questionnaire instead of three day food records, and it has been argued that the food frequency questionnaire overestimates the intake. 23, 24 It is a reasonable explanation as the patients still lost weight despite the high calorie intake. This is further strengthened as patients in the current study ceased to lose weight as soon as they reached 30 kcal/kg at the 6 month follow-up.
Another important aim was to explore the patient's choices of nutritional sources over time in relation to the treatment and problems with dysphagia, illustrated in Figures 2a, b and 3a-d. At diagnosis both groups managed oral intake to a high extent despite the location of the tumours and problems with dysphagia was low but increased depending on food consistency. During Energy intake and energy sources in HN cancer patients E Silander et al and after treatment enteral feeding was the major energy source for both groups even if the study group used enteral nutrition more and during these timepoints problems with dysphagia were at their peak. Dependency on enteral feeding for a longer time period is in accordance with previous studies [25] [26] [27] even though there is an ongoing debate as to whether a longer time period with the use of tube feeding may delay the return to normal oral intake and increase the risk for future oesophageal strictures and need for dilatation. [27] [28] [29] Six months after the start of treatment the oral intake had increased but the enteral feeding together with ONS still represented 44% of the energy intake in the study group but was as high as 39% in the control group, treated according to clinical praxis, further underscoring HN cancer patients' longlasting problems with dysphagia. The real improvement was found at the 12-month follow-up, at that time point and at the 2-year follow-up problems with dysphagia decreased and the oral intake was back to the same level as at time of diagnosis. Previous published studies have often been retrospective or prospective following the patients for a shorter time period. With the current study we have shown that HN cancer patients definitively need nutritional support for a longer time period than during and just after treatment. 2, 30 The strength of this study is its prospective longitudinal character including a randomised study cohort followed during 2 years at seven time points with well accepted methods and good compliance. The weakness is the rather few patients included receiving different treatment modalities and that both groups were followed by dieticians, which might have influenced the findings in the control groups as they also could have been exposed to nutritional advice upon request.
CONCLUSION
This randomised study shows, for the first time, the energy intake and energy sources in relation to energy requirements during 2 years in patients with advanced HN cancer tumours. Neither the study group, who had PEG to facilitate early enteral feeding, nor the control group reached their recommended energy intake until 6 months after start of treatment and during that time-period they were dependent on enteral feeding. After 1 year, problems with dysphagia had decreased and oral intake was the main energy source. Energy intake and energy sources in HN cancer patients E Silander et al
